Nitazoxanide as a New Local Adjunctive to Nonsurgical Treatment of Moderate Periodontitis
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of the study was to assess the effect of nitazoxanide delivered subgingivally as thermosensitive hydrogel on the clinical and biochemical outcomes of SRP in patients with moderate periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jul 2019
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 21, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedFebruary 24, 2021
February 1, 2021
9 months
February 21, 2021
February 21, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Probing depth
Probing depth was recorded at tested sites with graduated William's probe graduated in 1 mm increment. Readings were rounded to the nearest mm.
up to 6 months
Clinical attachment loss
Clinical attachment loss was recorded at tested sites with graduated William's probe graduated in 1 mm increment. Readings were rounded to the nearest mm.
up to 6 months
Bleeding on probing
Bleeding on probing was assessed at tested sites with graduated William's probe graduated in 1 mm increment, within 15 seconds after probing, using a dichotomous scoring system (+ and -) for presence or absence, respectively.
up to 6 months
Gingival index
Gingival index was assessed at 4 sites on six index teeth. Scores range from 0 to 3, with 0 being normal and 3 being severe inflammation
up to 6 months
Biochemical assessment of inflammation
This involved determination of the gingival crevicular fluid (GCF) levels of matrix metalloproteinase 8 (MPP-8). A GCF sample was taken from the area showing the deepest pocket depth around the treated area.The samples were diluted in phosphate buffer saline (PBS) up to 1 mL. After waiting for 15 min, the paper points were removed, and 500 μL were centrifuged at 400 g for 4 min, then frozen at -20°C pending MMP-8 analysis using Human Matrix metalloproteinase 8/Neutrophil collagenase (MMP-8) ELISA Kit according to the manufacturer instructions.
up to 6 months
Study Arms (2)
Scaling and Root Planing (SRP)
ACTIVE COMPARATORScaling and Root Planing with Nitazoxanide hydrogel
EXPERIMENTALInterventions
Supra- and sub-gingival calculus and debris were removed
Scaling and root planing was performed in combination with the subgingivally delivered thermosensitive Nitazoxanide hydrogel as adjunct antimicrobial therapy.
Eligibility Criteria
You may qualify if:
- Patients having probing depth (PD) ≥5 mm.
- Patients having bleeding on probing (BOP) in proximal tooth surface.
- Patients who could maintain an O'Leary plaque index ≤10 proceeded into the study.
You may not qualify if:
- Patients having any systemic disease that may affect the treatment outcomes.
- Smokers.
- Pregnant females.
- Patients receiving contraindicated medications, chemotherapy, or radiotherapy in the previous year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maha Talaablead
Study Sites (1)
Faculty of Dentistry, Alexandria University
Alexandria, 21527, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Maha R. Taalab, PhD
Faculty of Dentistry, Alexandria University, Egypt
- PRINCIPAL INVESTIGATOR
Sylvia Farid, BDS
Faculty of Dentistry, Alexandria University, Egypt
- STUDY DIRECTOR
Shaimaa Maklad, PhD
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt
- STUDY DIRECTOR
Labiba El-Khordagui, PhD
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt
- STUDY DIRECTOR
Maha El Tantawi, PhD
Faculty of Dentistry, Alexandria University, Egypt
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor, Oral Medicine, Periodontology, Oral Diagnosis and Oral Radiology department
Study Record Dates
First Submitted
February 21, 2021
First Posted
February 24, 2021
Study Start
July 20, 2019
Primary Completion
April 1, 2020
Study Completion
April 30, 2020
Last Updated
February 24, 2021
Record last verified: 2021-02